An ecosystem-scale litter and microplastics monitoring plan under the Arctic Monitoring and Assessment Programme (AMAP)

Lack of knowledge on levels and trends of litter and microplastics in the Arctic, is limiting our understanding of the sources, transport, fate, and effects is hampering global activities aimed at reducing litter and microplastics in the environment. To obtain a holistic view to managing litter and microplastics in the Arctic, we considered the current state of knowledge and methods for litter and microplastics monitoring in eleven environmental compartments representing the marine, freshwater, terrestrial, and atmospheric environments. Based on available harmonized methods, and existing data in the Arctic, we recommend prioritization of implementing litter and microplastics monitoring in the Arctic in four Priority 1 compartments—water, aquatic sediments, shorelines, and seabirds. One or several of these compartments should be monitored to provide benchmark data for litter and microplastics in the Arctic and, in the future, data on spatial and temporal trends. For the other environmental compartments, methods should be refined for future sources and surveillance monitoring, as well as monitoring of effects. Implementation of the monitoring activities should include community-based local components where possible. While organized as national and regional programs, monitoring of litter and microplastics in the Arctic should be coordinated, with a view to future pan-Arctic assessments.publishedVersio

Polar Data Forum IV – An Ocean of Opportunities

This paper reports on the Hackathon Sessions organised at the Polar Data Forum IV (PDF IV) (20–24 September 2021), during which 351 participants from 50 different countries discussed collaboratively about the latest developments in polar data management. The 4th edition of the PDF hosted lively discussions on (i) best practices for polar data management, (ii) data policy, (ii) documenting data flows into aggregators, (iv) data interoperability, (v) polar federated search, (vi) semantics and vocabularies, (vii) Virtual Research Environments (VREs), and (viii) new polar technologies. This paper provides an overview of the organisational aspects of PDF IV and summarises the polar data objectives and outcomes by describing the conclusions drawn from the Hackathon Sessions

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2

Mitochondrial physiology

As the knowledge base and importance of mitochondrial physiology to evolution, health and disease expands, the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive force provides the framework for developing a consistent theoretical foundation of mitochondrial physiology and bioenergetics. We follow the latest SI guidelines and those of the International Union of Pure and Applied Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems and thermodynamics of irreversible processes. The concept-driven constructive terminology incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to reproducibility between laboratories and thus support the development of data repositories of mitochondrial respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature facilitate effective transdisciplinary communication, education, and ultimately further discovery

Mitochondrial physiology

As the knowledge base and importance of mitochondrial physiology to evolution, health and disease expands, the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive force provides the framework for developing a consistent theoretical foundation of mitochondrial physiology and bioenergetics. We follow the latest SI guidelines and those of the International Union of Pure and Applied Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems and thermodynamics of irreversible processes. The concept-driven constructive terminology incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to reproducibility between laboratories and thus support the development of data repositories of mitochondrial respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature facilitate effective transdisciplinary communication, education, and ultimately further discovery

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

D6.4 Minutes of a workshop with coordinators of European Polar observing systems

<p>The EU-PolarNet 2 Workshop, arranged on 7th June 2022, aimed to collate, in a co-design process, actionable policy-level recommendations to accelerate the development of Integrated Polar Observing System (IPOS).<br> This deliverable (D6.4 Minutes of a Workshop with Coordinators of European Polar Observing System) presents the minutes of the meeting, including a detailed analysis of the workshop outcomes and the resulting recommendations. The recommendations will feed into a white paper to accelerate the development of a sustained and fully integrated Polar observing system (D6.7), published in 2024.<br> The workshop discussions were analysed with content analysis to extract the recommendations for the future development of IPOS. The overall vision of the future IPOS is an open, transparent, and poly-centric system adopting a tier or layered approach both regarding the engagement of its contributors and the observations conducted. Essential variables based on provision of societal benefits should be defined and should constitute the core of the system, allowing smaller operations on the side while also ensuring scientific excellence.<br> The recommended immediate actions to be taken into account in the development of IPOS include efforts on e.g. the identification of sustainable funding sources, and establishment of platforms and action groups for the joint development of different areas of IPOS such as infrastructure and data, governing, funding, and stakeholders. Long-term recommendations spanning over the years focus on e.g. the governing structure, technology advancement and funding instruments and agreements for IPOS. Overall, it was recommended to proceed step by step, starting immediately and adjusting the course of action during the development.</p&gt

An ecosystem-scale litter and microplastics monitoring plan under the Arctic Monitoring and Assessment Programme (AMAP)

Lack of knowledge on levels and trends of litter and microplastics in the Arctic, is limiting our understanding of the sources, transport, fate, and effects is hampering global activities aimed at reducing litter and microplastics in the environment. To obtain a holistic view to managing litter and microplastics in the Arctic, we considered the current state of knowledge and methods for litter and microplastics monitoring in eleven environmental compartments representing the marine, freshwater, terrestrial, and atmospheric environments. Based on available harmonized methods, and existing data in the Arctic, we recommend prioritization of implementing litter and microplastics monitoring in the Arctic in four Priority 1 compartments—water, aquatic sediments, shorelines, and seabirds. One or several of these compartments should be monitored to provide benchmark data for litter and microplastics in the Arctic and, in the future, data on spatial and temporal trends. For the other environmental compartments, methods should be refined for future sources and surveillance monitoring, as well as monitoring of effects. Implementation of the monitoring activities should include community-based local components where possible. While organized as national and regional programs, monitoring of litter and microplastics in the Arctic should be coordinated, with a view to future pan-Arctic assessments